PI3Kd inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax. (2020)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/bloodadvances.2020001584
PubMed Identifier: 32898249
Publication URI: http://europepmc.org/abstract/MED/32898249
Type: Journal Article/Review
Volume: 4
Parent Publication: Blood advances
Issue: 17
ISSN: 2473-9529